These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 15202292)

  • 1. Sharpening the intangibles edge.
    Lev B
    Harv Bus Rev; 2004 Jun; 82(6):109-16, 138. PubMed ID: 15202292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pension roulette: have you bet too much on equities?
    Stewart GB
    Harv Bus Rev; 2003 Jun; 81(6):104-9, 138. PubMed ID: 12800721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth crisis--and how to escape it.
    Slywotzky AJ; Wise R
    Harv Bus Rev; 2002 Jul; 80(7):72-83, 125. PubMed ID: 12140856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the strategic readiness of intangible assets.
    Kaplan RS; Norton DP
    Harv Bus Rev; 2004 Feb; 82(2):52-63, 121. PubMed ID: 14971269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's your real cost of capital?
    McNulty JJ; Yeh TD; Schulze WS; Lubatkin MH
    Harv Bus Rev; 2002 Oct; 80(10):114-21, 130. PubMed ID: 12389465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tread lightly through these accounting minefields.
    Sherman HD; Young SD
    Harv Bus Rev; 2001; 79(7):129-35, 146. PubMed ID: 11447613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four rules for taking your message to Wall Street.
    Hutton A
    Harv Bus Rev; 2001 May; 79(5):125-32, 166. PubMed ID: 11345909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. You have more capital than you think.
    Merton RC
    Harv Bus Rev; 2005 Nov; 83(11):84-94, 166. PubMed ID: 16299963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10 ways to create shareholder value.
    Rappaport A
    Harv Bus Rev; 2006 Sep; 84(9):66-77, 155. PubMed ID: 16967621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a share buyback right for your company?
    Pettit J
    Harv Bus Rev; 2001 Apr; 79(4):141-7, 170. PubMed ID: 11299690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing with giants. Survival strategies for local companies in emerging markets.
    Dawar N; Frost T
    Harv Bus Rev; 1999; 77(2):119-29, 187. PubMed ID: 10387768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How venture capital works.
    Zider B
    Harv Bus Rev; 1998; 76(6):131-9. PubMed ID: 10187243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expensing options solves nothing.
    Sahlman WA
    Harv Bus Rev; 2002 Dec; 80(12):90-6, 134. PubMed ID: 12510541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Take command of your growth.
    Treacy M; Sims J
    Harv Bus Rev; 2004 Apr; 82(4):127-33, 142. PubMed ID: 15077373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M&A needn't be a loser's game.
    Selden L; Colvin G
    Harv Bus Rev; 2003 Jun; 81(6):70-9, 137. PubMed ID: 12800718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making sense of corporate venture capital.
    Chesbrough HW
    Harv Bus Rev; 2002 Mar; 80(3):90-9, 133. PubMed ID: 11894386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capitalizing on capabilities.
    Ulrich D; Smallwood N
    Harv Bus Rev; 2004 Jun; 82(6):119-27, 138. PubMed ID: 15202293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoid the four perils of CRM.
    Rigby DK; Reichheld FF; Schefter P
    Harv Bus Rev; 2002 Feb; 80(2):101-6, 108-9, 130. PubMed ID: 11894676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IT doesn't matter.
    Carr NG
    Harv Bus Rev; 2003 May; 81(5):41-9, 128. PubMed ID: 12747161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.